<DOC>
	<DOCNO>NCT00919633</DOCNO>
	<brief_summary>The purpose study evaluate continuous subcutaneous delivery interferon alfa-2b use external drug pump combination use oral ribavirin provide safe effective treatment patient chronic hepatitis C infection compare patient receive standard treatment .</brief_summary>
	<brief_title>Safety Efficacy Study Compare Continuous Infusion Interferon With Standard Care Chronic Hepatitis C</brief_title>
	<detailed_description>The study include patient diagnose chronic hepatitis C genotype 1 infection receive previous interferon anti-HCV treatment .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<criteria>Signed patient consent form Genotype 1 chronic HCV detectable HCV RNA No previous treatment HCV infection Hepatitis B human immunodeficiency virus negative screen visit Able willing follow contraception requirement Screening laboratory value , test , physical exam within acceptable range Weight 40 kg 125 kg Proficiency use external pump infusion system Current plan enrollment another investigational device drug study Anticipated inability complete clinic visit comply study procedure History , current medical condition , could impact safety subject study Autoimmune hepatitis , suspect hepatocellular carcinoma , decompensated liver disease , know liver disease HCV Alcoholism substance abuse &lt; 6 documented month sobriety Known allergy sensitivity interferon ribavirin Any condition , opinion Investigator , would make subject unsuitable enrollment could interfere subject participate completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>hepatitis C</keyword>
	<keyword>HCV</keyword>
	<keyword>genotype</keyword>
	<keyword>sustained virological response</keyword>
	<keyword>rapid virological response</keyword>
	<keyword>interferon</keyword>
</DOC>